Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1200865

LOTEPREDNOL ETABONATE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CCOC(=O)O[C@]1(C(=O)OCCl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C

Basic Information

ChEMBL ID CHEMBL1200865
Name LOTEPREDNOL ETABONATE
Phase Approved
Structure Type MOL
InChI Key DMKSVUSAATWOCU-HROMYWEYSA-N
Therapeutic ✓ Yes

Known Names

Alrex CDDD 5604 CDDD-5604 CDDD5604 Eysuvis HGP-1 Inveltys KPI-121 Lotemax Lotemax sm Loteprednol Loteprednol etabonate +2 more
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
20
Publications
14
Known Names
8
Indications
1
Mechanisms

Molecular Properties

467.0
MW (Da)
3.92
ALogP
7
HBA
1
HBD
99.1
PSA (Ų)
0.49
QED
0
Ro5 Violations
4
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1998
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Topical

Flags

Natural Product
USAN Stem -pred-
USAN Year 1990

Extended Properties

Molecular Formula C24H31ClO7
MW 466.96
Aromatic Rings 0
Heavy Atoms 32
NP-Likeness 1.86

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Glucocorticoid receptor agonist AGONIST Glucocorticoid receptor

Indications

Conjunctivitis, Allergic Dry Eye Syndromes Eye Diseases Inflammation Uveitis, Anterior Cataract Blepharitis Eye Pain

ATC Classification

S01BA14
loteprednol
Level 1: SENSORY ORGANS
Level 2: OPHTHALMOLOGICALS

Activity Summary

IC50 3 meas. best 4.81

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
ATP-binding cassette sub-family C member 3
CHEMBL5918
IC50 4.81 4.81 15520.0 1
SARS-CoV-2
CHEMBL4303835
IC50 4.75 4.75 17920.0 1
Bile salt export pump
CHEMBL6020
IC50 4.39 4.39 40400.0 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
37468498 10.1038/s41467-023-40064-9 Gamma-aminobutyric acid receptor subunit alpha-1 2
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2B 2
- 10.6019/CHEMBL4651402 Vero C1008 2
- 10.21203/rs.3.rs-23951/v1 SARS-CoV-2 2
37468498 10.1038/s41467-023-40064-9 5-hydroxytryptamine receptor 2A 2
- 10.6019/CHEMBL4651402 SARS-CoV-2 2
37468498 10.1038/s41467-023-40064-9 Alpha-1A adrenergic receptor 2
- 10.6019/CHEMBL4495565 SARS-CoV-2 2
37468498 10.1038/s41467-023-40064-9 Alpha-2A adrenergic receptor 2
37468498 10.1038/s41467-023-40064-9 Nuclear receptor subfamily 1 group I member 2 2
37468498 10.1038/s41467-023-40064-9 Androgen receptor 2
37468498 10.1038/s41467-023-40064-9 Muscarinic acetylcholine receptor M2 2
- 10.6019/CHEMBL4513141 Candida albicans 1
- 10.6019/CHEMBL4513141 Klebsiella pneumoniae 1
- 10.6019/CHEMBL4513141 Escherichia coli 1
- 10.6019/CHEMBL4513141 Cryptococcus neoformans 1
- 10.21203/rs.3.rs-23951/v1 ADMET 1
- 10.1101/2020.04.03.023846 SARS-CoV-2 1
23956101 10.1093/toxsci/kft176 ATP-binding cassette sub-family C member 3 1

Data from ChEMBL 36 via Core Engine